Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5367_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
02.09.2026
Размер:
21 Мб
Скачать
76 NeuroPhytomedicine
https://t.me/medicina_free
Guzman, and Jorge Fuentealba. 2019. “17 Oxo sparteine and lupanine, obtained from Cytisus scoparius, exert a neuroprotection against soluble oligomers of amyloid-β toxicity by nicotinic acetylcholine receptors.” Journal of Alzheimer’s Disease 67: 343–356. https://doi.org/10.3233/JAD-180945, https://content.iospress.com/articles/
journal-of-alzheimers-disease/jad180945.
Gul, Amara, Jehan Bakht, and Farah Mehmood. 2019. “Huperzine-A response to cognitive
impairment and task switching decits in patients with Alzheimer’s disease.” Journal of the Chinese Medical Association 82 (1): 40–43.
Guo, Shi-Yin, Guo-Ping Yang, De-Jian Jiang, Feng Wang, Tao Song, Xing-He Tan, and Zhen-
Qiu Sun. 2008. “Protection of capsaicin against hypoxia–reoxygenation-induced apop­tosis of rat hippocampal neurons.” Canadian Journal of Physiology and Pharmacology 86 (11): 785–792. https://doi.org/10.1139/y08-083, https://cdnsciencepub.com/doi/abs/
10.1139/Y08-083.
Han, J., Q. Qu, J. Qiao, and J. Zhang. 2017. “Vincamine alleviates amyloid-β 25-35
peptides-induced cytotoxicity in PC12 cells.” Pharmacognosy Magazine 13 (49): 123–128. https://doi.org/10.4103/0973-1296.196309.
Hemendinger, Richelle A., Edward J. Armstrong, Rafal Persinski, Julianne Todd, Jean-Luc
Mougeot, Franklin Volvovitz, and Jeffrey Rosenfeld. 2008. “Huperzine A provides neuroprotection against several cell death inducers using in vitro model systems of motor neuron cell death.” Neurotoxicity Research 13: 49– 61.
Hsieh, Ting-Yang, Yi Chang, and Su-Jane Wang. 2022. “Piperine provides neuroprotection
against kainic acid-induced neurotoxicity via maintaining NGF signalling pathway.” Molecules 27 (9): 2638. https://www.mdpi.com/1420-3049/27/9/2638.
Hua, Shiyao, Jiayue Liu, Yiwei Zhang, Juan Li, Xinhui Zhang, Lin Dong, Yunsheng Zhao,
and Xueyan Fu. 2019. “Piperine as a neuroprotective functional component in rats with cerebral ischemic injury.” Food Science & Nutrition 7 (11): 3443–3451.
Huang, S. L., H. B. He, K. Zou, C. H. Bai, Y. H. Xue, J. Z. Wang, and J. F. Chen. 2014.
“Protective effect of tomatine against hydrogen peroxide-induced neurotoxicity in neuroblastoma (SH-SY5Y) cells.” Journal of Pharmacy and Pharmacology 66 (6): 844–854. https://doi.org/10.1111/jphp.12205.
Huertas, Adriana, William D. Wessinger, Yuri V. Kucheryavykh, Priscila Sanabria, Misty
J. Eaton, Serguei N. Skatchkov, Legier V. Rojas, Gerónimo Maldonado-Martínez, and Mikhail Y. Inyushin. 2015. “Quinine enhances the behavioral stimulant effect of cocaine in mice.” Pharmacology Biochemistry and Behavior 129: 26–33.
Hussien, Hend M., Aml Abd-Elmegied, Doaa A. Ghareeb, Hani S. Hafez, Hany E. A. Ahmed,
and Nehad Abd El-Moneam. 2018. “Neuroprotective effect of berberine against envi­ronmental heavy metals-induced neurotoxicity and Alzheimer’s-like disease in rats.” Food and Chemical Toxicology 111: 432– 4 4 4.
Jiang, Wenxiao, Wenjie Wei, Marta A. Gaertig, Shihua Li, and Xiao-Jiang Li. 2015.
“Therapeutic effect of berberine on Huntington’s disease transgenic mouse model.” PloS One 10 (7): e0134142.
Jiang, Xia, Lin-Wei Jia, Xiao-Hong Li, Xiang-Shu Cheng, Jia-Zhao Xie, Zhi-Wei Ma, Wei-Jie
Xu, Yue Liu, Yun Yao, and Lai-Ling Du. 2013. “Capsaicin ameliorates stress-induced Alzheimer’s disease-like pathological and cognitive impairments in rats.” Journal of Alzheimer’s Disease 35 (1): 91–105.
Jin, Gui-Lin, Li-Mian Hong, Hai-Ping Liu, Rong-Cai Yue, Zu-Cheng Shen, Jian Yang, Ying
Xu, Hui-Hui Huang, Yi Li, Bo-Jun Xiong, Yan-Ping Su, and Chang-Xi Yu. 2021. “Koumine modulates spinal microglial M1 polarization and the inammatory response through the notch-RBP-Jκ signaling pathway, ameliorating diabetic neuropathic pain in rats.” Phytomedicine 90: 153640. https://doi.org/10.1016/j.phymed.2021.153640,
https://www.sciencedirect.com/science/article/pii/S0944711321001835.
The Neuroprotective Effect of Alkaloids and Synthetic Derivatives
https://t.me/medicina_free
Jin, Gui-Lin, Rong-Cai Yue, Sai-Di He, Li-Mian Hong, Ying Xu, and Chang-Xi Yu. 2018.
“Koumine decreases astrocyte-mediated neuroinammation and enhances autophagy, contributing to neuropathic pain from chronic constriction injury in rats.” Frontiers in Pharmacology 9: 989.
Kandil, Lamia Said, Ragwa M. Farid, Safaa S. ElGamal, and Amira Sayed Hanafy. 2021.
“Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection poten­tials in rat brains via antioxidant effect.” Drug Development and Industrial Pharmacy 47 (5): 735–740.
Karmirian, Karina, Lívia Goto-Silva, Juliana Minardi Nascimento, Marcelo N. Costa,
José Alexandre Salerno, Isis Moraes Ornelas, Bart Vanderborght, Daniel Martins­de-Souza, and Stevens Rehen. 2021. “Proteomic changes induced by harmine in human brain organoids reveal signaling pathways related to neuroprotection.” bioRxiv
2021.06.16.448740.
Kasabova-Angelova, Alexandra, Magdalena Kondeva-Burdina, Javor Mitkov, Maya
Georgieva, Virginia Tzankova, and Alexander Zlatkov. 2020. “Neuroprotective and MAOB inhibitory effects of a series of caffeine-8-thioglycolic acid amides.” Brazilian Journal of Pharmaceutical Sciences 56.
Kaushik, Pooja, Mubashshir Ali, Mohd Salman, Heena Tabassum, and Suhel Parvez. 2021.
“Harnessing the mitochondrial integrity for neuroprotection: Therapeutic role of piper­ine against experimental ischemic stroke.” Neurochemistry International 149: 105138.
https://doi.org/10.1016/j.neuint.2021.105138, https://www.sciencedirect.com/science/ ar ticle/pii/S0197018621001844.
Khalili, Mohsen, Mitra Alavi, Elham Esmaeil-Jamaat, Tourandokht Baluchnejadmojarad,
and Mehrdad Roghani. 2018. “Trigonelline mitigates lipopolysaccharide-induced learning and memory impairment in the rat due to its anti-oxidative and anti­inammatory effect.” International Immunopharmacology 61: 355–362. https://
doi.org/10.1016/j.intimp.2018.06.019, https://www.sciencedirect.com/science/article/pii/ S1567576918302704.
Khatibi, Nikan H., Vikram Jadhav, Shelton Charles, Jeffrey Chiu, John Buchholz, Jiping
Tang, and John H. Zhang. 2011. “Capsaicin pre-treatment provides neurovascular pro­tection against neonatal hypoxic-ischemic brain injury in rats.” Acta Neurochirurgica. Supplement 111: 225–230.
Kohnen-Johannsen, Kathrin Laura, and Oliver Kayser. 2019. “Tropane alkaloids: Chemistry,
pharmacology, biosynthesis and production.” Molecules 24 (4): 796. https://www.mdpi.
com/1420-3049/24/4/796.
Kondeva-Burdina, Magdalena, Javor Mitkov, Iva Valkova, Lily Peikova, Maya Georgieva,
and Alexander Zlatkov. 2022. “Quantitative structure–neurotoxicity assessment and in vitro evaluation of neuroprotective and MAO-B inhibitory activities of series N′- substituted 3-(1,3,7-trimethyl-xanthin-8-ylthio)propanehydrazides.” Molecules 27 (16):
5321. https://www.mdpi.com/1420-3049/27/16/5321.
Konrath, Eduardo L., Katiane Santin, Melissa Nassif, Alexandra Latini, Amélia Henriques,
and Christianne Salbego. 2008. “Antioxidant and pro-oxidant properties of boldine on hippocampal slices exposed to oxygen–glucose deprivation in vitro.” Neurotoxicology 29 (6): 1136–1140.
Krieglstein, Josef, and Ralf Rischke. 1991. “Vinpocetine increases the neuroprotective effect
of adenosine in vitro.” European Journal of Pharmacology 205 (1): 7–10. https://doi.
org/10.1016/0014-2999(91)90762-F, https://www.sciencedirect.com/science/article/pii/ 001429999190762F.
Kumar, Anil, Atish Prakash, and Deeksha Pahwa. 2011. “Galantamine potentiates the protec-
tive effect of rofecoxib and caffeic acid against intrahippocampal kainic acid-induced cognitive dysfunction in rat.” Brain Research Bulletin 85 (3–4): 158–168.
77
78
https://t.me/medicina_free
Kurek, Joanna. 2019. Alkaloids: Their Importance in Nature and Human Life. BoD–Books
on Demand.
Lee, Yu-Young, Jin-Sun Park, Yea-Hyun Leem, Jung-Eun Park, Do-Yeon Kim, Youn-Hee
Choi, Eun-Mi Park, Jihee Lee Kang, and Hee-Sun Kim. 2019. “The phosphodiester­ase 10 inhibitor papaverine exerts anti-inammatory and neuroprotective effects via the PKA signaling pathway in neuroinammation and Parkinson’s disease mouse models.” Journal of Neuroinammation 16 (1): 246. htt ps://doi.org/10.1186/s12974- 019-1649-3.
Leem, Y. H., J. S. Park, J. E. Park, D. Y. Kim, and H. S Kim. 2021. “Papaverine exerts neuro-
protective effect by inhibiting NLRP3 inammasome activation in an MPTP-induced microglial priming mouse model challenged with LPS.” Biomolecules & Therapeutics 29 (3): 295–302. https://doi.org/10.4062/biomolther.2021.039.
Leem, Yea-Hyun, Jin-Sun Park, Jung-Eun Park, Do-Yeon Kim, Jihee Lee Kang, and Hee-
Sun Kim. 2020. “Papaverine inhibits α-synuclein aggregation by modulating neuroin­ammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson’s disease.” Biomedicine & Pharmacotherapy 130: 110576. https://
doi.org/10.1016/j.biopha.2020.110576, https://www.sciencedirect.com/science/article/pii/ S0753332220307691.
Li, Chao-Yue, Li-Ming Zhao, Xi-Wen Shi, and Jia-Dong Zhang. 2014. “Lobeline shows
protective effects against MPTP-induced dopaminergic neuron death and attenuates behavior decits in animals.” Experimental and Therapeutic Medicine 7 (2): 375–378.
https://doi.org/10.3892/etm.2013.1413.
Li, Yu-Jiao, Qi Yang, Kun Zhang, Yan-Yan Guo, Xu-Bo Li, Le Yang, Ming-Gao Zhao, and
Yu-Mei Wu. 2013. “Cytisine confers neuronal protection against excitotoxic injury by down-regulating GluN2B-containing NMDA receptors.” NeuroToxicology 34: 219–225.
https://doi.org/10.1016/j.neuro.2012.09.009, https://www.sciencedirect.com/science/article/ pi i /S0161813X120 02215.
Ling, Qian, Ming Liu, Min-Xia Wu, Ying Xu, Jian Yang, Hui-Hui Huang, and Chang-Xi
Yu. 2014. “Anti-allodynic and neuroprotective effects of koumine, a benth alkaloid, in a rat model of diabetic neuropathy.” Biological and Pharmaceutical Bulletin 37 (5): 858–864.
Liu, Ding-Quan, Shui-Chun Mao, Hai-Yan Zhang, Xiao-Qing Yu, Mei-Tang Feng, Bin Wang,
Li-Hua Feng, and Yue-Wei Guo. 2013. “Racemosins a and b, two novel bisindole alka­loids from the green alga Caulerpa racemosa.” Fitoterapia 91: 15–20.
Liu, Peifang, Hui Li, Yueqiu Wang, Xiaolin Su, Yang Li, Meiling Yan, Lan Ma, and Hui
Che. 2020. “Harmine ameliorates cognitive impairment by inhibiting NLRP3 inam­masome activation and enhancing the BDNF/TrkB signaling pathway in STZ-induced diabetic rats.” Frontiers in Pharmacology 11: 535.
Lopes, João P., Glauco Tarozzo, Angelo Reggiani, Daniele Piomelli, a nd Andrea Cavalli. 2013.
“Galantamine potentiates the neuroprotective effect of memantine against NMDA­induced excitotoxicity.” Brain and Behavior 3 (2): 67–74.
Ma, Ning-Tian, Ru Zhou, Ren-Yuan Chang, Yin-Ju Hao, Lin Ma, Shao-Ju Jin, Juan Du, Jie
Zheng, Cheng-Jun Zhao, Yang Niu, Tao Sun, Wei Li, Kazuo Koike, Jian-Qiang Yu, and Yu-Xiang Li. 2015. “Protective effects of aloperine on neonatal rat primary cultured hippocampal neurons injured by oxygen–glucose deprivation and reperfusion.” Journal of Natural Medicines 69 (4): 575–583. https://doi.org/10.1007/s11418-015-0928-2.
Machado-Filho, João Ananias, Alyne Oliveira Correia, Anyssa Brilhante Aires Montenegro,
Maria Elizabeth Pereira Nobre, Gilberto Santos Cerqueira, Kelly Rose Tavares Neves, Maria da Graça Naffah-Mazzacoratti, Esper Abrão Cavalheiro, Gerly Anne de Castro Brito, and Glauce Socorro de Barros Viana. 2014. “Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inammatory cytokines and histone deacetylase inhibitions.” Behavioural Brain Research 264: 116–125.
NeuroPhytomedicine
The Neuroprotective Effect of Alkaloids and Synthetic Derivatives
https://t.me/medicina_free
Mao, Qing-Qiu, Zhen Huang, Siu-Po Ip, Yan-Fang Xian, and Chun-Tao Che. 2012. “Protective
effects of piperine against corticosterone-induced neurotoxicity in PC12 cells.” Cellular and Molecular Neurobiology 32: 531–537.
Mao, Xiao-Yuan, Hong-Hao Zhou, Xi Li, and Zhao-Qian Liu. 2016. “Huperzine A alleviates
oxidative glutamate toxicity in hippocampal HT22 cells via activating BDNF/TrkB­dependent PI3K/Akt/mTOR signaling pathway.” Cellular and Molecular Neurobiology 36: 915–925.
Mirzaie, M., M. Khalili, Z. Kiasalari, and M. Roghani. 2016. “Neuroprotective and antiapop-
totic potential of trigonelline in a striatal 6-hydroxydopamine rat model of Parkinson’s disease.” Neurophysiology 48 (3): 176–183. https://doi.org/10.1007/s11062-016-9586 -6.
Nasrnezhad, Reza, Sohrab Halalkhor, Farzin Sadeghi, and Fereshteh Pourabdolhossein. 2021.
“Piperine improves experimental autoimmune encephalomyelitis (EAE) in Lewis rats through its neuroprotective, anti-inammatory, and antioxidant effects.” Molecular Neurobiology 58 (11): 5473–5493. https://doi.org/10.1007/s12035-021-02497-5.
Nyakas, Csaba, Klára Felszeghy, Róbert Szabó, Jan N. Keijser, Paul G.M. Luiten, Zsolt
Szombathelyi, and Károly Tihanyi. 2009. “Neuroprotective effects of vinpocetine and its major metabolite cis-apovincaminic acid on NMDA-induced neurotoxicity in a rat entorhinal cortex lesion model.” CNS Neuroscience & Therapeutics 15 (2): 89–99.
ht t ps://doi.org/10.1111/j.1755-5949.2009.00078.x, https://onlinelibrary.wiley.com/doi/abs/
10.1111/j.1755-5949.2009.00 0 78.x.
Ogunrinade, Folashade A., Victoria U. Iwuanyanwu, Satyajit D. Sarker, and Olumayokun A.
Olajide. 2023. “Neuroprotection by skimmianine in lipopolysaccharide-activated BV-2 microgl ia.” Molecules 28 (3): 1317.
Olajide, Olumayokun A., Harsharan S. Bhatia, Antonio C. P. de Oliveira, Colin W. Wright,
and Bernd L. Fiebich. 2013a. “Anti-neuroinammatory properties of synthetic cryp­tolepine in human neuroblastoma cells: Possible involvement of NF-κB and p38 MAPK inhibition.” European Journal of Medicinal Chemistry 63: 333–339. https://
doi.org/10.1016/j.ejmech.2013.02.004, https://www.sciencedirect.com/science/article/ pii/S0223523413000901.
. 2013b. “Inhibition of neuroinammation in LPS-activated microglia by crypto-
lepine.” Evidence-Based Complementary and Alternative Medicine 2013: 459723.
https://doi.org/10.1155/2013/459723.
Olawepo, A, A. O. Ishola, M. S. Ajao, O. J. Olayemi, and L. A. Olayaki. 2017. “Atropine
exposure in adolescence predispose to adult memory loss in Wistar rats.” International Journal of Biological and Chemical Sciences 11 (5): 1937–1947.
Pákáski, Magdolna, Marietta Hugyecz, Péter Sántha, Gábor Jancsó, Annamária Bjelik,
Ágnes Domokos, Zoltán Janka, and János Kálmán. 2009. “Capsaicin promotes the amyloidogenic route of brain amyloid precursor protein processing.” Neurochemistry International 54 (7): 426–430. https://doi.org/10.1016/j.neuint.20 09.01.012, https://
www.sciencedirect.com/science/article/pii/S0197018609000308.
Papaliagkas, V., A. Anogianaki, G. Anogianakis, and G. Ilonidis. 2007. “The proteins and
the mechanisms of apoptosis: A mini-review of the fundamentals.” Hippokratia 11 (3): 108–113.
Paškulin, Roman, Polona Jamnik, Marko Živin, Peter Raspor, and Borut Štrukelj. 2006.
“Ibogaine affects brain energy metabolism.” European Journal of Pharmacology 552 (1–3): 11–14.
Petrovska, B. B. 2012. “Historical review of medicinal plants’ usage.” Pharmacognosy
Reviews 6 (11): 1–5. https://doi.org/10.4103/0973-7847.95849.
Polak, P. E., S. Kalinin, D. Braun, A. Sharp, S. X. Lin, and D. L. Feinstein. 2012. “The vin-
camine derivative vindeburnol provides benet in a mouse model of multiple sclerosis: Effects on the locus coeruleus.” Journal of Neurochemistry 121 (2): 206–16. https://doi.
org /10.1111/j.1471- 4159.2012.07673.x.
79
80 NeuroPhytomedicine
https://t.me/medicina_free
Pravalika, Kanta, Deepaneeta Sarmah, Harpreet Kaur, Kanchan Vats, Jackson Saraf,
Madhuri Wanve, Kiran Kalia, Anupom Borah, Dileep R. Yavagal, Kunjan R. Dave, and Pallab Bhattacharya. 2019. “Trigonelline therapy confers neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic stroke.” Life Sciences 216: 49–58. https://doi.org/10.1016/j.lfs.2018.11.014, https://www.science
direct.com/science/article/pii/S0024320518307203.
Qi, Wen, Jiahong Sun, James W Simpkins, and Dan Yuan. 2015. “Isolation and identication
of twelve metabolites of isocorynoxeine in rat urine and their neuroprotective activities in HT22 cell assay.” Planta Medica 81 (01): 46 –55.
Qiu, Hong-Qiang, Ying Xu, Gui-Lin Jin, Jian Yang, Ming Liu, Su-Ping Li, and Chang-Xi Yu.
2015. “Koumine enhances spinal cord 3α-hydroxysteroid oxidoreductase expression and activity in a rat model of neuropathic pain.” Molecular Pain 11: s12990-015-0050-1.
Qiu, Zhengguo, Kefeng Wang, Chao Jiang, Yuqiang Su, Xiaoying Fan, Jing Li, Sha Xue, and
Li Yao. 2020. “Trigonelline protects hippocampal neurons from oxygen-glucose depri­vation-induced injury through activating the PI3K/Akt pathway.” Chemico-Biological Interactions 317: 108946. https://doi.org/10.1016/j.cbi.2020.108946, https://www.science
direct.com/science/article/pii/S0009279719311901.
Ressler, Kerry J, and Charles B Nemeroff. 2000. “Role of serotonergic and noradrenergic
systems in the pathophysiology of depression and anxiety disorders.” Depression and Anxiety 12 (S1): 2–19.
Riad M., and Candice C. Hithe. 2023. Scopolamine. In StatPearls [Internet]. StatPearls
Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554397/.
Saglam, Emre, Selim Zırh, Canan Cakir Aktas, Sevda Fatma Muftuoglu, and Burcak Bilginer.
2021. “Papaverine provides neuroprotection by suppressing neuroinammation and apoptosis in the traumatic brain injury via RAGE- NF-<kappa>B pathway.” Journal of Neuroimmunology 352: 577476. https://doi.org/10.1016/j.jneuroim.2021.577476, https://
www.sciencedirect.com/science/article/pii/S0165572821000035.
Sharma, Tejas, Vishal Airao, Nimesh Panara, Devendra Vaishnav, Vishavas Ranpariya, Navin
Sheth, and Sachin Parmar. 2014. “Solasodine protects rat brain against ischemia/reper­fusion injury through its antioxidant activity.” European Journal of Pharmacology 725: 40–46. https://doi.org/10.1016/j.ejpha r.2014.01.005, https://www.sciencedirect.com/
science/article/pii/S0014299914000065.
Shoaib, Rana Muhammad, Jing-Yang Zhang, Xiao-Fang Mao, and Yong-Xiang Wang. 2019.
“Gelsemine a nd koumine, pr incipal active ingredients of Gelsemium, exhibit mechanical antiallodynia via spinal glycine receptor activation-induced allopregnanolone biosynthe­sis.” Biochemical Pharmacology 161: 136 –148. https://doi.org/10.1016/j.bcp.2019.01.014,
https://www.sciencedirect.com/science/article/pii/S0006295219300206.
Solmaz, Volkan, Mahmut Kaya, Fatma Betul Uslu, Ozum Atasoy, and Oytun Erbaş. 2022.
“Papaverine has therapeutic potential for sepsis-induced neuropathy in rats, possibly via the modulation of HMGB1-RAGE axis and its antioxidant prosperities.” Journal of Investigative Surgery 35 (1): 7–13. https://doi.org/10.1080/08941939.2020.1809751.
Sun, Lingyan, Xia Tian, Lingshan Gou, Xin Ling, Ling Wang, Yan Feng, Xiaoxing Yin, and
Yi Liu. 2013. “Benecial synergistic effects of concurrent treatment with theanine and caffeine against cerebral ischemia–reperfusion injury in rats.” Canadian Journal of Physiology and Pharmacology 91 (7): 562–569.
Sun, Piyun, Shuyan Zhang, Yanyan Li, and Lihua Wang. 2014. “Harmine mediated neuro-
protection via evaluation of glutamate transporter 1 in a rat model of global cerebral ischemia.” Neuroscience Letters 583: 32–36.
Tan, Xiang-Shan, Jing-Yi Ma, Ru Feng, Chao Ma, Wen-Jing Chen, Yu-Peng Sun, Jie Fu, Min
Huang, Chi-Yu He, and Jia-Wen Shou. 2013. “Tissue distribution of berberine and its metabolites after oral administration in rats.” PloS One 8 (10): e77969.
The Neuroprotective Effect of Alkaloids and Synthetic Derivatives
https://t.me/medicina_free
Tárnok, K., E. Kiss, P. G. M. Luiten, C. Nyakas, K. Tihanyi, K. Schlett, and U. L. M. Eisel.
2008. “Effects of vinpocetine on mitochondrial function and neuroprotection in pri­mary cortical neurons.” Neurochemistry International 53 (6): 289–295. https://doi.org/
10.1016/j.neuint.2008.08.003, https://www.sciencedirect.com/science/article/pii/S0197
018608001320.
Taveira, Marcos, Carla Sousa, Patrícia Valentão, Federico Ferreres, João P. Teixeira, and
Paula B. Andrade. 2014. “Neuroprotective effect of steroidal alkaloids on glutamate­induced toxicity by preserving mitochondrial membrane potential and reducing oxida­tive stress.” The Journal of Steroid Biochemistry and Molecular Biology 140: 106–115.
https://doi.org/10.1016/j.jsbmb.2013.12.013, https://www.sciencedirect.com/science/article/ pii/S0960076013002860.
Toledo, Juan P., Eduardo J. Fernández-Pérez, Ildete L. Ferreira, Daniela Marinho, Nicolas
O. Riffo-Lepe, Benjamin N. Pineda-Cuevas, Luis F. Pinochet-Pino, Carlos F. Burgos, A. Cristina Rego, and Luis G. Aguayo. 2021. “Boldine attenuates synaptic failure and mitochondrial deregulation in cellular models of Alzheimer’s disease.” Frontiers in Neuroscience 15: 617821.
Tundis, Rosa, Federica Menichini, Filomena Conforti, Monica R. Loizzo, Marco Bonesi,
Giancarlo Statti, and Francesco Menichini. 2009. “A potential role of alkaloid extracts from Salsola species (Chenopodiaceae) in the treatment of Alzheimer’s disease.” Journal of Enzyme Inhibition and Medicinal Chemistry 24 (3): 818–824.
Vajda, F. J. 2002a. “Neuroprotection and neurodegenerative disease.” Journal of Clinical
Neuroscience 9 (1): 4–8. https://doi.org/10.1054/jocn.2001.1027.
Vajda, Frank JE. 2002b. “Neuroprotection and neurodegenerative disease.” Journal of Clinical
Neuroscience 9 (1): 4–8.
Villalpando-Vargas, Fridha, Laura Medina-Ceja, Anne Santerre, and Edgar A. Enciso-
Madero. 2020. “The anticonvulsant effect of sparteine on pentylenetetrazole-induced seizures in rats: A behavioral, electroencephalographic, morphological and molecular st udy.” Journal of Molecular Histology 51: 503–518.
Wang, Zhi-Fei, Juan Wang, Hai-Yan Zhang, and Xi-Can Tang. 2008. “Huperzine A exhibits
anti-inammatory and neuroprotective effects in a rat model of transient focal cerebral ischemia.” Journal of Neurochemistry 106 (4): 1594–1603.
Xiao, Xianghua, Juntian Liu, Jingwen Hu, Tianxia Li, and Yuanhui Zhang. 2007. “Protective
effect of protopine on the focal cerebral ischaemic injury in rats.” Basic & Clinical Pharmacology & Toxicology 101 (2): 85–89.
Xiao, Xianghu a, Juntian Liu, Jingwen Hu, Xiuping Zhu, Hua Yang, Chaoyun Wang, and Yuanhui
Zhang. 2008. “Protective effects of protopine on hydrogen peroxide-induced oxidative injury of PC12 cells via Ca2+ antagonism and antioxidant mechanisms.” European Journal of Pharmacology 591 (1): 21–27. https://doi.org/10.1016/j.ejphar.2008.06.045,
https://www.sciencedirect.com/science/article/pii/S0014299908006286.
Xiong, Bo-Jun, Ying Xu, Gui-Lin Jin, Ming Liu, Jian Yang, and Chang-Xi Yu. 2017.
“Analgesic effects and pharmacologic mechanisms of the Gelsemium alkaloid kou­mine on a rat model of postoperative pain.” Scientic Reports 7 (1): 14269. https://doi.
org/10.1038/s41598-017-14714-0.
Xu, Zhifang, Wei Feng, Qian Shen, Nannan Yu, Kun Yu, Shenjun Wang, Zhigang Chen, Seiji
Shioda, and Yi Guo. 2017. “Rhizoma coptidis and berberine as a natural drug to combat aging and aging-related diseases via anti-oxidation and AMPK activation.” Aging and Disease 8 (6): 760.
Yang, Wei, Yu-Hua Chen, Hao Liu, and Hong-Dang Qu. 2015. “Neuroprotective effects of
piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s dis­ease mouse model.” International Journal of Molecular Medicine 36 (5): 1369–1376.
https://doi.org/10.3892/ijmm.2015.2356.
81
82
https://t.me/medicina_free
Yi, Chenju, Pascal Ezan, Paola Fernandez, Julien Schmitt, Juan C. Saez, Christian Giaume,
and Annette Koulakoff. 2017. “Inhibition of glial hemichannels by boldine treatment reduces neuronal suffering in a murine model of Alzheimer’s disease.” Glia 65 (10): 1607–1625.
Zang, Jiankun, Yousheng Wu, Xuanlin Su, Tianyuan Zhang, Xionglin Tang, Dan Ma, Yufeng
Li, Yanfang Liu, Ze’an Weng, Xuanzhuo Liu, Chi Kwan Tsang, Anding Xu, and Dan Lu. 2021. “Inhibition of PDE1-b by vinpocetine regulates microglial exosomes and polarization through enhancing autophagic ux for neuroprotection against isch­emic stroke.” Frontiers in Cell and Developmental Biology 8. https://doi.org/10.3389/
fcell.2020.616590, https://www.frontiersin.org/articles/10.3389/fcell.2020.616590.
Zhong, Zeqi, Yuan Tao, and Hui Yang. 2015. “Treatment with harmine ameliorates functional
impairment and neuronal death following traumatic brain injury.” Molecular Medicine Reports 12 (6): 7985–7991.
Zhou, Ji-Yin, and Shi-Wen Zhou. 2012. “Protection of trigonelline on experimental diabetic
peripheral neuropathy.” Evidence-Based Complementary and Alternative Medicine 2012: 164219. https://doi.org/10.1155/2012/164219.
Zhou, Jiyin, Xiaohuang Du, Min Long, Zuo Zhang, Shiwen Zhou, Jianyun Zhou, and
Guisheng Qian. 2016. “Neuroprotective effect of berberine is mediated by MAPK signaling pathway in experimental diabetic neuropathy in rats.” European Journal of Pharmacology 774: 87–94.
Zhou, Xi-Qiao, Xiao-Ning Zeng, Hui Kong, and Xiu-Lan Sun. 2008. “Neuroprotective
effects of berberine on stroke models in vitro and in vivo.” Neuroscience Letters 447 (1): 31–36.
Zhu, Qing-Luan, Yu-Xiang Li, Ru Zhou, Ning-Tian Ma, Ren-Yuan Chang, Teng-Fei Wang, Yi
Zhang, Xiao-Ping Chen, Yin-Ju Hao, and Shao-Ju Jin. 2014. “Neuroprotective effects of oxysophocarpine on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion.” Pharmaceutical Biology 52 (8): 1052–1059.
NeuroPhytomedicine
Molecular Mechanism
https://t.me/medicina_free
5
of Action of Phytoconstituents in Neuropsychiatric Disorders
Urmila Aswar, Rashmi Patil, Likhit Akotkar, and Atmaram Pawar
5.1 INTRODUCTION
Neuropsychiatric disorders are highly prevalent and signicantly have increased the global disease burden. They are cumulatively complex diseases with a poorly described mechanism, and research into them is progressing slowly. Approximately
970.1 million individuals worldwide suffer from mental problems, a number that has signicantly increased since the global pandemic in 2020. Stress, major depres­sive disorder (MDD), anxiety, psychosis, schizophrenia (SZ), bipolar disorder (BD), insomnia and obsessive-compulsive disorder (OCD) are some of the most common neuropsychiatric disorders (Figure 5.1). Drawing a distinction between “disorder” and “normality” of a person’s wellness is a crucial part of classifying and identifying mental diseases (Sotille et al, 2022). Recently phytomedicines have gained immense demand as a prophylactic as well as therapeutic use for numerous neuropsychiatric disorders. Herbs are becoming more and more popular all over the world due to their effectiveness in treating sickness due to their multitarget mechanisms and the draw­backs of pharmaceutical treatments in terms of side effects and expense. Current chapter will discuss the various phytoconstituents studied clinically and preclini­cally for neuropsychiatric disorders and emphasis is also given to understand their mechanism of actions.
5.2 PHYTOCONSTITUENTS FOR STRESS-RELATED DISORDERS
Stress is a divisive condition caused by stressors, putting at risk the homeostasis nec­essary for survival and well-being. The stress system is a complex array of molecu­lar, cellular and neuroendocrine components. According to physiological theory, the sympathetic-adrenomedullary axis (SAM axis) and adrenergic system are imme­diately activated in the body’s response to stress, followed by the hypothalamus­pituitary-adrenal axis (HPA axis), which are the main players in stress (Figure 5.2).
83DOI: 10.1201/9781003389781-5
84
https://t.me/medicina_free
FIGURE 5.1 Diagrammatic representation of various phytoconstituents and their role in major neuropsychiatric disorders (stress, anxiety, depression and psychosis). Abbreviations: corticotropin-releasing hormone (CRH), dopamine (DA), nor-epinephrine (NE), gamma­aminobutyric acid (GABA), n-methyl-d-aspartate (NMDA).
NeuroPhytomedicine
It affects the cognitive, reward and fear systems in the brain, and centrally it pro­duces structural and functional alterations that result in neuropsychiatric diseases such as anxiety, depression and sleeplessness (Musazzi et al, 2018; Patriquin and Mathew, 2017; Yang et al, 2015). The cytokine pathway, the neurotransmitter path­way (dopamine, serotonin) and the neuroendocrine pathway (cortisol) are the three primary mechanisms implicated in stress. The body releases arginine, vasopressin, corticotropin-releasing hormone (CRH), pro-opiomelanocortin-derived peptides, neuropeptide Y, activating locus coeruleus (LC) and autonomic norepinephrine cen­tres in the brainstem known as allostasis for survival and adaptation to the changing internal and external environment. The thyroid hormone axis, growth, reproduc­tive, gastrointestinal, cardiorespiratory, metabolic and immunologic systems are all affected at the periphery. Many neuropathological and emotional disorders, includ­ing depression, SZ, post-traumatic stress disorder and cognitive impairment, may be caused by long-term chronic stress. By enhancing sleep, food and exercise, as well as integrating meditation and some herbs into our food, medicine or diet can reducestress.
The families of plants, Solanaceae, Araliaceae, Lamiaceae, Crassulaceae, Asteraceae and Scrophulariaceae are the most frequently utilised as anti-stress remedies around the world. The most popular herbs for stress management include
Withania somnifera (WS), Rosmarinus ofcinalis, Panax ginseng, Rhodiola rosea L., Matricaria recutita L., Bacopa monnieri, Convolvulus pluricaulis, Eleutherococcus senticosus, Schisandra chinensis and Centella asiatica L. WS,
Molecular Mechanism of Action of Phytoconstituents
https://t.me/medicina_free
FIGURE 5.2 Diagrammatic representation of stress pathway, representing HPA axis dys­regulation. Stress activates a complex network of major endocrine hormones known as the HPA axis. Hypothalamus secretes CRH into the bloodstream and increases the activity of the sympathetic nervous system, signalling the pituitary gland to secrete adrenocorticotropic hormone. ACTH released into the bloodstream travels down to the adrenal cortex, resulting in adrenal glands to secrete glucocorticoids like cortisol. Cortisol has receptors in almost all cell types and helps our body cope with the immediate stress by negative feedback mecha­nism that impact back on the function of the hypothalamus and pituitary. In case of extreme persistent stress, it overloads the HPA axis and it continues to release hormones on acceler­ated basis leading to desensitisation and stop recognising signals to stop producing corti­sol. It results in non-functioning of negative feedback loop leading to various metabolical, neuropsychological and inammatory disorders. Introduction of herbal phytoconstituents results in blockage of stress response by modulation of the HPA axis through corticotrophin­releasing hormone and cortisol. Abbreviations: Hypothalamic-pituitary-adrenal (HPA) axis, corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH) and reactive oxygen species (ROS).
85
also known as ashwagandha, reduces stress symptoms primarily via modulating the HPA axis, SAM axis, gamma-aminobutyric acid (GABA)ergic and serotoner­gic pathways, as well as other stress-related pathways. The active phytochemical, withaferin-A, withanolide acts mainly through the suppression of cortisol and cor­ticosterone which get elevated during stress-induced HPA axis dysregulation. A recent clinical trial involving 60 healthy adults between the ages of 18 and 75 with below 20 value on the perceived stress scale (PSS) was studied for adaptogenic and anxiolytic effects of ashwagandha root extract (Salve et al, 2019). PSS is a 14-item instrument to measure stress. For eight weeks, they received either ashwagandha